comparemela.com

Metastatic Breast Cancer Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First-Line HER2+ Metastatic Breast Cancer Trials in Focus

Heather McArthur, MD, emphasizes the influence of recent and ongoing clinical trials, specifically DESTINY-Breast09 and HER2CLIMB-05, in steering the treatment paradigm in 1st-line HER2-positive metastatic breast cancer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.